Common canine prostatic disorders include benign prostatic hypertrophy (BPH
), prostatitis, prostatic cysts and prostatic adenocarcinoma. BPH is a spon
taneous and age-related disorder of intact male dogs, which occurs in more
than 80% male dogs over 5 years of age, and which is associated with clinic
al signs of sanguinous prostatic fluid, constipation and dysuria. BPH signs
respond to castration or to finasteride treatment (0.1-0.5 mg/kg per os on
ce daily), as finasteride inhibits conversion of testosterone to dihydrotes
tosterone, causing prostatic involution via apoptosis. BPH often occurs con
currently with prostatic infection, abscessation, cysts and neoplasia in th
e intact dog, and finasteride-induced prostatic involution may be beneficia
l in treatment of all of these conditions except neoplasia. Two studies sug
gest that risk of prostatic adenocarcinoma is increased in neutered, compar
ed to intact male dogs. Although canine prostatic neoplasia, unlike human p
rostatic neoplasia, usually does not respond to androgen deprivation, recen
t reports of prostatic intraepithelial neoplasia (PIN) in a high percentage
of older male dogs, with and without prostatic adenocarcinoma, suggests th
at PIN may be a precursor to adenocarcinoma in the dog as it is believed to
be in man. (C) 2000 Elsevier Science B.V. All rights reserved.